Yazan Alderazi, MD
Vascular Neurology · Webster, TXNPI 1316113251
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,850 of the $9,711 with a category attached, or 60.2%. Medical Device Business Services, Inc. accounts for 66.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $5,026 and has fallen 91.6% since, to $421 in 2025.
Across 73 payments — averaging $133.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$6K
- Johnson & Johnson$839
- Microvention, Inc.$554
- Route 92 Medical, Inc.$427
- Siemens Medical Solutions USA, Inc.$339
- Imperative Care, Inc$272
- plus $786 from 9 others
Across 16 payments — averaging $1093.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$17K
What the payments were for
- Consulting fees$5,85060%
- Travel & lodging$8158%
- Food & beverage$3,04731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 5 | $6,496 |
| Johnson & Johnson | 30 | $839 |
| Microvention, Inc. | 6 | $554 |
| Route 92 Medical, Inc. | 2 | $427 |
| Siemens Medical Solutions USA, Inc. | 5 | $339 |
| Imperative Care, Inc | 6 | $272 |
| Penumbra, Inc. | 2 | $214 |
| Stryker | 2 | $194 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| AstraZeneca | 4 | $78 |
| AbbVie | 3 | $60 |
| Asahi Intecc USA, Inc. | 4 | $54 |
| Qapel Medical Inc | 1 | $28 |
| Viz.ai, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$4,696
- TRUFILL$4,696
- EMBOGUARD$1,935
- WEB$293
- 8F Base Camp Sheath System$190
- ZEPOSIA$125
- BALLOON CATHETER$123
- WEB Aneurysm Embolization System$123
- CorPath Imaging System$122
- Penumbra System$119
- ZOOM 88-T LARGE DISTAL PLATFORM$116
- Embotrap$109
- ARTIS icono biplane$103
How this compares
$9,711 in reported general payments places this provider in the 80th percentile of 76 vascular neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 11 | $4,783 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $78 | $4,78311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 76 vascular neurology providers in Texas.
Other vascular neurology in Webster
- Ameer HassanHarlingen$1M
- John VolpiHouston$407K
- Lee BirnbaumSan Antonio$195K
- Amrou SarrajHouston$182K
- Sunil ShethHouston$54K
- Steven WarachAustin$32K
- Jefferson MileyAustin$28K
- Hamidreza SaberAustin$22K
- Haris KamalHouston$21K
- Sean SavitzHouston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.